Premium
Preparation of an I‐124 labelled doxorubicin conjugate for in vivo assessment of polymer targeted anticancer therapy
Author(s) -
Hadfield J. A.,
Pietrzynski G.,
Bailey J.,
Alakhov V.,
Sosabowski J. K.,
Zweit J.,
Ranson M.
Publication year - 2001
Publication title -
journal of labelled compounds and radiopharmaceuticals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.432
H-Index - 47
eISSN - 1099-1344
pISSN - 0362-4803
DOI - 10.1002/jlcr.25804401130
Subject(s) - doxorubicin , chemistry , conjugate , in vivo , derivative (finance) , polymer , combinatorial chemistry , pharmacology , chemotherapy , organic chemistry , medicine , mathematical analysis , mathematics , microbiology and biotechnology , biology , financial economics , economics
A lipophilic doxorubicin derivative (DOXIB), as a potential PET radiotracer for DOX/polymer targeting, has been prepared and characterised against DOX.